The FDA granted fast track status to IBI363 for the treatment of patients with advanced squamous lung cancer after prior ...
Researchers from Zhengzhou University and affiliated organizations published data from a study that aimed to assess the expression levels of histone modifier enzymes in esophageal squamous cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback